UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 321

Sortiert nach

Pitfalls in PSMA imaging: [18F]rhPSMA-7-PET/CT reveals presence of chrondrosarcoma

European journal of nuclear medicine and molecular imaging, 2021-08, Vol.48 (9), p.3007-3008

2021

Link zum Volltext

Verfügbarkeit prüfen

[99cmTc]Tc-PSMA-I&S-SPECT/CT: experience in prostate cancer imaging in an outpatient center

EJNMMI research, 2020-05, Vol.10 (1), p.45-45, Article 45

2020

Link zum Volltext

Verfügbarkeit prüfen

Influence of localization of PSMA-positive oligo-metastases on efficacy of metastasis-directed external-beam radiotherapy—a multicenter retrospective study

European journal of nuclear medicine and molecular imaging, 2020-07, Vol.47 (8), p.1852-1863

2020

Link zum Volltext

Verfügbarkeit prüfen

Three-dimensional fat-saturated T1-weighted Cartesian volumetric interpolated breath-hold examination (VIBE) for the diagnosis of aortitis in patients with suspected large vessel vasculitis: a comparative study with 18F-FDG PET applying fully integrated PET/MRI

Clinical radiology, 2019-09, Vol.74 (9), p.731.e11-731.e19

2019

Link zum Volltext

Verfügbarkeit prüfen

Clinical experience with 100 consecutive patients treated with Lu-177-labeled PSMA-I&T radioligand therapy for metastatic castration-resistant prostate cancer: Final analysis

Annals of oncology, 2018-10, Vol.29, p.viii291-viii291

2018

Link zum Volltext

Verfügbarkeit prüfen

Impact of 68Ga-PSMA-PET imaging on target volume definition and guidelines in radiation oncology - a patterns of failure analysis in patients with primary diagnosis of prostate cancer

Radiation oncology (London, England), 2018-03, Vol.13 (1), p.1-8, Article 36

2018

Link zum Volltext

Verfügbarkeit prüfen

Circulating tumor cells versus objective response assessment predicting survival in metastatic castration-resistant prostate cancer patients treated with docetaxel chemotherapy

Journal of cancer research and clinical oncology, 2015-08, Vol.141 (8), p.1457-1464

2015

Link zum Volltext

Verfügbarkeit prüfen

Reply: Not All Gatekeepers Are Theranostics

Journal of Nuclear Medicine, 2023-10, Vol.64 (10), p.1662-1663

2023

Link zum Volltext

Verfügbarkeit prüfen

Patterns of failure after radical prostatectomy in prostate cancer – implications for radiation therapy planning after 68Ga-PSMA-PET imaging

European journal of nuclear medicine and molecular imaging, 2017-09, Vol.44 (10), p.1656-1662

2017

Link zum Volltext

Verfügbarkeit prüfen

Loco-regional recurrence after surgical treatment of oral squamous cell carcinoma: Proposals for follow-up imaging based on literature, national guidelines and institutional experience

Journal of cranio-maxillo-facial surgery, 2015-10, Vol.43 (8), p.1546-1552

2015

Link zum Volltext

Verfügbarkeit prüfen

Local recurrence after radical prostatectomy and additive radiation – can PSMA-radioguided surgery prolong therapy-free survival?

European urology open science (Online), 2020-07, Vol.19, p.e1222

2020

Link zum Volltext

Verfügbarkeit prüfen

Diagnostic performance of 18F-rhPSMA-7.3 PET in men with newly diagnosed unfavourable intermediate to very high-risk prostate cancer: Results from the phase 3 LIGHTHOUSE study

European urology, 2023-02, Vol.83, p.S1417-S1418

2023

Link zum Volltext

Verfügbarkeit prüfen

A0989 - Diagnostic performance of 18F-rhPSMA-7.3 PET in men with newly diagnosed unfavourable intermediate to very high-risk prostate cancer: Results from the phase 3 LIGHTHOUSE study

European urology, 2023-02, Vol.83, p.S1417-S1418

2023

Link zum Volltext

Verfügbarkeit prüfen

Impact of 68Ga-PSMA-11 PET on the management of biochemically recurrent prostate cancer in a prospective single-arm clinical trial

European urology open science (Online), 2020-07, Vol.19, p.e1215-e1216

2020

Link zum Volltext

Verfügbarkeit prüfen

Measurements and Classifications in Musculoskeletal Radiology

1, 2013

Link zum Volltext

Verfügbarkeit prüfen

PO-1471 PSMA-PET-based Definitive Radiotherapy for Patients with Prostate Cancer - Outcome and Feasibility

Radiotherapy and oncology, 2023-05, Vol.182, p.S1191-S1192

2023

Link zum Volltext

Verfügbarkeit prüfen

Diagnose und Ausbreitungsdiagnostik des Prostatakarzinoms: Multiparametrische und multimodale Bildgebung

Forum (Heidelberg), 2016-03, Vol.31 (2), p.115-120

2016

Link zum Volltext

Verfügbarkeit prüfen

Prostate-specific membrane antigen-radioguided surgery salvage lymph node dissection: Experience with fifty oligorecurrent prostate cancer patients in a single center

European urology, 2024-03, Vol.85, p.S1536-S1537

2024

Link zum Volltext

Verfügbarkeit prüfen

A0616 - Prostate-specific membrane antigen-radioguided surgery salvage lymph node dissection: Experience with fifty oligorecurrent prostate cancer patients in a single center

European urology, 2024-03, Vol.85, p.S1536-S1537

2024

Link zum Volltext

Verfügbarkeit prüfen

Utility of multimodal cardiac imaging with PET/MRI in cardiac sarcoidosis: implications for diagnosis, monitoring and treatment

European heart journal, 2014-02, Vol.35 (5), p.312-312

2014

Link zum Volltext

Verfügbarkeit prüfen

1414P Treatment efficacy and safety of 177Lu-PSMA radioligand therapy in octogenarians with metastatic castration-resistant prostate cancer

Annals of oncology, 2022-09, Vol.33, p.S1191-S1192

2022

Link zum Volltext

Verfügbarkeit prüfen

CT-Based Radiomics Can Improve the Prediction of Recurrent Prostate Cancer-Positive Lymph Nodes

International journal of radiation oncology, biology, physics, 2019-09, Vol.105 (1), p.E142-E143

2019

Link zum Volltext

Verfügbarkeit prüfen

Complete biochemical response below 0.1 ng/ml predicts long-term therapy-free survival of patients treated with salvage lymph node dissection via PSMA-radioguided surgery

European urology, 2023-02, Vol.83, p.S1626

2023

Link zum Volltext

Verfügbarkeit prüfen

A1122 - Complete biochemical response below 0.1 ng/ml predicts long-term therapy-free survival of patients treated with salvage lymph node dissection via PSMA-radioguided surgery

European urology, 2023-02, Vol.83, p.S1626-S1626

2023

Link zum Volltext

Verfügbarkeit prüfen

1392P Lutetium-177-prostate-specific membrane antigen therapy (177Lu-PSMA) in patients (Pts) with prior radium-223 (223Ra): Safety and effectiveness outcomes

Annals of oncology, 2022-09, Vol.33, p.S1180

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 321

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(255)
Mit Volltextzugriff
(268)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(119)
Science & Technology
(109)
Life Sciences & Biomedicine
(105)
Male
(78)
Prostate Cancer
(61)
Oncology
(52)
Aged
(40)
Middle Aged
(40)
Medicine
(38)
Medicine & Public Health
(38)
Radiology, Nuclear Medicine & Medical Imaging
(31)
Imaging
(29)
Prostatic Neoplasms - Diagnostic Imaging
(29)
Radiology
(27)
Positron Emission
(26)
Nuclear Medicine
(25)
Retrospective Studies
(25)
Patients
(24)
Tomography
(24)
Antigens
(23)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Pitfalls in PSMA imaging: [18F]rhPSMA-7-PET/CT reveals presence of chrondrosarcoma

[99cmTc]Tc-PSMA-I&S-SPECT/CT: experience in prostate cancer imaging in an outpatient center

Influence of localization of PSMA-positive oligo-metastases on efficacy of metastasis-directed external-beam radiotherapy—a multicenter retrospective study

Three-dimensional fat-saturated T1-weighted Cartesian volumetric interpolated breath-hold examination (VIBE) for the diagnosis of aortitis in patients with suspected large vessel vasculitis: a comparative study with 18F-FDG PET applying fully integrated PET/MRI

Clinical experience with 100 consecutive patients treated with Lu-177-labeled PSMA-I&T radioligand therapy for metastatic castration-resistant prostate cancer: Final analysis

Impact of 68Ga-PSMA-PET imaging on target volume definition and guidelines in radiation oncology - a patterns of failure analysis in patients with primary diagnosis of prostate cancer

Circulating tumor cells versus objective response assessment predicting survival in metastatic castration-resistant prostate cancer patients treated with docetaxel chemotherapy

Reply: Not All Gatekeepers Are Theranostics

Patterns of failure after radical prostatectomy in prostate cancer – implications for radiation therapy planning after 68Ga-PSMA-PET imaging

Loco-regional recurrence after surgical treatment of oral squamous cell carcinoma: Proposals for follow-up imaging based on literature, national guidelines and institutional experience

Local recurrence after radical prostatectomy and additive radiation – can PSMA-radioguided surgery prolong therapy-free survival?

Diagnostic performance of 18F-rhPSMA-7.3 PET in men with newly diagnosed unfavourable intermediate to very high-risk prostate cancer: Results from the phase 3 LIGHTHOUSE study

A0989 - Diagnostic performance of 18F-rhPSMA-7.3 PET in men with newly diagnosed unfavourable intermediate to very high-risk prostate cancer: Results from the phase 3 LIGHTHOUSE study

Impact of 68Ga-PSMA-11 PET on the management of biochemically recurrent prostate cancer in a prospective single-arm clinical trial

Measurements and Classifications in Musculoskeletal Radiology

PO-1471 PSMA-PET-based Definitive Radiotherapy for Patients with Prostate Cancer - Outcome and Feasibility

Diagnose und Ausbreitungsdiagnostik des Prostatakarzinoms: Multiparametrische und multimodale Bildgebung

Prostate-specific membrane antigen-radioguided surgery salvage lymph node dissection: Experience with fifty oligorecurrent prostate cancer patients in a single center

A0616 - Prostate-specific membrane antigen-radioguided surgery salvage lymph node dissection: Experience with fifty oligorecurrent prostate cancer patients in a single center

Utility of multimodal cardiac imaging with PET/MRI in cardiac sarcoidosis: implications for diagnosis, monitoring and treatment

1414P Treatment efficacy and safety of 177Lu-PSMA radioligand therapy in octogenarians with metastatic castration-resistant prostate cancer

CT-Based Radiomics Can Improve the Prediction of Recurrent Prostate Cancer-Positive Lymph Nodes

Complete biochemical response below 0.1 ng/ml predicts long-term therapy-free survival of patients treated with salvage lymph node dissection via PSMA-radioguided surgery

A1122 - Complete biochemical response below 0.1 ng/ml predicts long-term therapy-free survival of patients treated with salvage lymph node dissection via PSMA-radioguided surgery

1392P Lutetium-177-prostate-specific membrane antigen therapy (177Lu-PSMA) in patients (Pts) with prior radium-223 (223Ra): Safety and effectiveness outcomes

Suchergebnisse filtern